橫店影視(603103.SH)第三季實現票房收入5.72億元
格隆匯11月6日丨橫店影視(603103.SH)公佈,報告期內(7-9月),公司新開直營影院15家,新增銀幕91塊,實現票房收入5.72億元,市場佔有率3.69%,觀影人次1892.72萬;加盟影城實現票房收入8995.44萬元,觀影人次303.87萬。
截至報告期末(1-9月),公司共擁有已開業直營影院355家,2229塊銀幕,累計票房16.23億元,市場佔有率3.66%,實現觀影人次5004.00萬;公司共擁有加盟影院84家,470塊銀幕,累計票房2.72億元,實現觀影人次852.54萬。(注:上述票房收入均不含服務費)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.